Louphrasitthiphol Pakavarin

Institute of Medicine
Official title
Assistant Professor
Research projects
膵がん幹細胞と微小環境の相互作用を担うMiTを断ち切る新規治療法の開発2021 -- 2022LOUPHRASITTHIPHOL PAKAVARINJapan Society for the Promotion of Science/Grant-in-Aid for Early-Career Scientists4,680,000Yen
Conference, etc.
  • Acetylation reprograms MITF target selectivity
    Louphrasitthiphol Pakavarin
    The 19th International Congress of the Society for Melanoma Research/2022-10-17--2022-10-20
  • Isorhamnetin restricts cancer-associated fibroblasts (CAFs) phenotypic plasticity, poising them towards tumour-restraining myCAFs. Potential use of isorhamnetin as neoadjuvant in pancreatic ductal adenocarcinoma (PDAC)
    Ganbold Munkhzul; Louphrasitthiphol Pakavarin; Yoshinor...
    AACR Special Conference: Pancreatic Cancer/2022-09-13--2022-09-16

(Last updated: 2023-08-21)